These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1625 related items for PubMed ID: 16243172

  • 1. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.
    Marx RE, Sawatari Y, Fortin M, Broumand V.
    J Oral Maxillofac Surg; 2005 Nov; 63(11):1567-75. PubMed ID: 16243172
    [Abstract] [Full Text] [Related]

  • 2. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
    Grewal VS, Fayans EP.
    Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
    [Abstract] [Full Text] [Related]

  • 3. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.
    Bamias A, Kastritis E, Bamia C, Moulopoulos LA, Melakopoulos I, Bozas G, Koutsoukou V, Gika D, Anagnostopoulos A, Papadimitriou C, Terpos E, Dimopoulos MA.
    J Clin Oncol; 2005 Dec 01; 23(34):8580-7. PubMed ID: 16314620
    [Abstract] [Full Text] [Related]

  • 4. Dental endosseous implants in patients on bisphosphonate therapy.
    Scully C, Madrid C, Bagan J.
    Implant Dent; 2006 Sep 01; 15(3):212-8. PubMed ID: 16966893
    [Abstract] [Full Text] [Related]

  • 5. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
    Walter C, Al-Nawas B, Grötz KA, Thomas C, Thüroff JW, Zinser V, Gamm H, Beck J, Wagner W.
    Eur Urol; 2008 Nov 01; 54(5):1066-72. PubMed ID: 18602738
    [Abstract] [Full Text] [Related]

  • 6. Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases.
    Dimitrakopoulos I, Magopoulos C, Karakasis D.
    Int J Oral Maxillofac Surg; 2006 Jul 01; 35(7):588-93. PubMed ID: 16687238
    [Abstract] [Full Text] [Related]

  • 7. Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates.
    Farrugia MC, Summerlin DJ, Krowiak E, Huntley T, Freeman S, Borrowdale R, Tomich C.
    Laryngoscope; 2006 Jan 01; 116(1):115-20. PubMed ID: 16481822
    [Abstract] [Full Text] [Related]

  • 8. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P.
    Clin Ther; 2007 Aug 01; 29(8):1548-58. PubMed ID: 17919538
    [Abstract] [Full Text] [Related]

  • 9. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy.
    Migliorati CA, Schubert MM, Peterson DE, Seneda LM.
    Cancer; 2005 Jul 01; 104(1):83-93. PubMed ID: 15929121
    [Abstract] [Full Text] [Related]

  • 10. Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report.
    Merigo E, Manfredi M, Meleti M, Corradi D, Vescovi P.
    J Oral Pathol Med; 2005 Nov 01; 34(10):613-7. PubMed ID: 16202082
    [Abstract] [Full Text] [Related]

  • 11. Imaging findings of bisphosphonate-related osteonecrosis of the jaw with emphasis on early magnetic resonance imaging findings.
    Krishnan A, Arslanoglu A, Yildirm N, Silbergleit R, Aygun N.
    J Comput Assist Tomogr; 2009 Nov 01; 33(2):298-304. PubMed ID: 19346864
    [Abstract] [Full Text] [Related]

  • 12. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment.
    Marx RE, Cillo JE, Ulloa JJ.
    J Oral Maxillofac Surg; 2007 Dec 01; 65(12):2397-410. PubMed ID: 18022461
    [Abstract] [Full Text] [Related]

  • 13. Bisphosphonate-associated osteonecrosis of the jaw: conclusions based on an analysis of case series.
    Landesberg R, Wilson T, Grbic JT.
    Dent Today; 2006 Aug 01; 25(8):52, 54-7. PubMed ID: 16925161
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Osteonecrosis of the jaw as an adverse bisphosphonate event: three cases of bone metastatic prostate cancer patients treated with zoledronic acid.
    García Sáenz JA, López Tarruella S, García Paredes B, Rodríguez Lajusticia L, Villalobos L, Díaz Rubio E.
    Med Oral Patol Oral Cir Bucal; 2007 Sep 01; 12(5):E351-6. PubMed ID: 17767097
    [Abstract] [Full Text] [Related]

  • 16. Bisphosphonate-induced necrosis of the jaws: a reconstructive nightmare.
    Gevorgyan A, Enepekides DJ.
    Curr Opin Otolaryngol Head Neck Surg; 2008 Aug 01; 16(4):325-30. PubMed ID: 18626250
    [Abstract] [Full Text] [Related]

  • 17. Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients.
    Friedrich RE, Blake FA.
    Anticancer Res; 2007 Aug 01; 27(4A):1841-5. PubMed ID: 17649782
    [Abstract] [Full Text] [Related]

  • 18. Sinus tracts--an early sign of bisphosphonate-associated osteonecrosis of the jaws?
    Mawardi H, Treister N, Richardson P, Anderson K, Munshi N, Faiella RA, Woo SB.
    J Oral Maxillofac Surg; 2009 Mar 01; 67(3):593-601. PubMed ID: 19231786
    [Abstract] [Full Text] [Related]

  • 19. Uncovering the cause of "phossy jaw" Circa 1858 to 1906: oral and maxillofacial surgery closed case files-case closed.
    Marx RE.
    J Oral Maxillofac Surg; 2008 Nov 01; 66(11):2356-63. PubMed ID: 18940506
    [Abstract] [Full Text] [Related]

  • 20. Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies.
    Boonyapakorn T, Schirmer I, Reichart PA, Sturm I, Massenkeil G.
    Oral Oncol; 2008 Sep 01; 44(9):857-69. PubMed ID: 18282788
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 82.